Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk
source: pixabay.com

Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk
FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma
source: pixabay.com

FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma

The FDA will review parsaclisib as a treatment for Non-Hodgkin lymphoma (NHL) after accepting Incyte's New Drug Application (NDA). Specifically, the NDA was submitted for the treatment of relapsed or…

Continue Reading FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma